Is there a link between CD146, a novel adhesion molecule and other markers of endothelial dysfunction in nephrotic syndrome and continuous ambulatory peritoneal dialysis?

Thrombosis Research

Volumn 115, Issue 1-2, 2005, Pages 19-24

  Małyszko, Jolanta ^a   Małyszko, Jacek S ^a   Myśliwiec, Michał ^a  

^a Medical University   (Poland)

Author keywords

Adhesion molecules; CAPD; CD146; Endothelium; Nephrotic syndrome

Indexed keywords

BIOLOGICAL MARKER; CELL ADHESION MOLECULE; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; PADGEM PROTEIN; THROMBOMODULIN; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR;

ADULT; AGED; ANALYTIC METHOD; ARTICLE; BLOOD SAMPLING; CELL DAMAGE; CLINICAL ARTICLE; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; ENDOTHELIUM CELL; ENDOTHELIUM LESION; FEMALE; HUMAN; MALE; NEPHROTIC SYNDROME; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

ADULT; AGED; ANTIGENS, CD; ANTIGENS, CD146; BIOLOGICAL MARKERS; BIOPSY; CASE-CONTROL STUDIES; CELL ADHESION MOLECULES; ENDOTHELIUM, VASCULAR; FEMALE; HEMOSTASIS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; LINEAR MODELS; LIPOPROTEINS; LIVER; MALE; MIDDLE AGED; NEPHROTIC SYNDROME; NEURAL CELL ADHESION MOLECULES; PERITONEAL DIALYSIS, CONTINUOUS AMBULATORY;

EID: 9644252868     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2004.06.025     Document Type: Article

References (23)

1. R. Ross The pathogenesis of atherosclerosis: a perspective for the 1990s Nature 362 1993 801 809
2. R. Ross Atherosclerosis-an inflammatory disease N. Engl. J. Med. 340 1998 115 126
3. T. Bombeli, M. Mueller, and A. Haeberli Anticoagulant properties of the vascular endothelium Thromb. Haemost. 77 1997 408 423
4. J. Malyszko, J.S. Malyszko, and M. Mysliwiec Comparison of hemostatic disturbances between patients on CAPD and HD Perit. Dial. Int. 21 2001 158 165
5. S. Kuriyama, H. Tomonari, H. Yoshida, M. Hikita, and O. Sakai Endothelial cell dysfunction in patients with impaired renal function Nippon Jinzo Gakkaishi 38 1996 372 378
6. S.H. Jacobson, N. Egberg, B. Hylander, and J. Lundahl Correlation between soluble markers of endothelial dysfunction in patients with renal failure Am. J. Nephrol. 22 2002 42 47
7. C.H. Bolton, L.G. Downs, J.G. Victory, J.F. Dwight, C.R. Tomson, and M.I. Mackness Endothelial dysfunction in chronic renal failure: roles of lipoprotein oxidation and proinflammatory cytokines Nephrol. Dial. Transplant. 16 2001 1189 1197
8. J.D. Ordonez, R.A. Hiatt, E.J. Killebrew, and B.H. Fireman The increased risk of coronary heart disease associated with nephrotic syndrome Kidney Int. 44 1993 638 642
9. N. Bardin, F. Anfosso, J.M. Masse, E. Cramer, F. Sabatier, and A. Le Bivic Identification of CD146 as a component of the endothelial junction involved in the control of cell-cell cohesion Blood 98 2001 3677 3684
10. N. Bardin, V. Moal, F. Anfosso, L. Daniel, P. Brunet, and J. Sampol Soluble CD146, a novel endothelial marker, is increased in physiopathological settings linked to endothelial junctional alteration Thromb. Haemost. 90 2003 915 920
11. M. Kobayashi, N. Yorioka, and M. Yamakido Hypercoagulability and secondary hyperfibrinolysis may be related to abnormal lipid metabolism in patients treated with continuous ambulatory peritoneal dialysis Nephron 76 1997 56 61
12. F. Llach Hypercoagulability, renal vein thrombosis in the nephrotic syndrome Kidney Int. 28 1985 429 439
13. K. Kario, T. Matsuo, T. Yamada, and M. Matsuo Increased tissue factor pathway inhibitor levels in uremic patients on regular hemodialysis Thromb. Haemost. 71 1994 275 279
14. J. Malyszko, T. Urano, R. Knofler, A. Taminato, T. Yoshimi, and Y. Takada Daily variations of platelet aggregation in relation to blood and plasma serotonin in diabetes Thromb. Res. 75 1994 569 576
15. J.C. Gris, B. Branger, F. Vecina, B. Sabadani, J. Fourcade, and J.F. Schved Increased cardiovascular risk factors and features of endothelial activation and dysfunction in dialyzed uremic patients Kidney Int. 46 1994 807 813
16. J.S. Malyszko, J. Malyszko, D. Pawlak, K. Pawlak, W. Buczko, and M. Mysliwiec Serotonergic mechanism are involed in the pathogenesis of thrombotic complicationin rHuEPO-treated hemodialyzed patients Nephron 75 2000 612 618
17. A.D. Blann, J. Hopkins, J. Winkles, and A.C. Wainwright Plasma and serum von Willebrand factor antigen levels in connective tissue disorders Ann. Clin. Biochem. 29 1992 67 71
18. A.D. Blann, and D.A. Taberner A reliable marker of endothelial cell dysfunction: does it exist? Br. J. Haematol. 90 1995 244 248
19. M. Bonomini, M. Reale, P. Santarelli, S. Stuard, N. Settefrati, and A. Albertazzi Serum levels of soluble adhesion molecules in chronic renal failure and dialysis patients Nephron 79 1998 399 407
20. N. Ishiwata, K. Takio, M. Katayama, K. Watanabe, K. Titani, and Y. Ikeda Altenatively spliced isoform of P-selectin is present in vivo as soluble molecule J. Biol. Chem. 38 1994 23708 23715
21. J. Malyszko, J.S. Malyszko, and M. Mysliwiec Endothelial cell injury markers in chronic renal failure on conservative treatment and continuous ambulatory peritoneal dialysis Kidney Blood Press Res. 27 2004 71 77
22. R.A. Ariens, M. Moia, E. Rivolta, C. Ponticelli, and P.M. Mannucci High levels of tissue factor pathway inhibitor in patients with nephrotic proteinuria Thromb. Haemost. 82 1999 1020 1023
23. J.S. Malyszko, J. Malyszko, and M. Mysliwiec Tissue factor and inhibitor of the blood coagulation pathway in nephrotic syndrome Pol. Arch. Med. Wew. 101 1999 301 305